ERP44 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.047000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.814200E-01
Normal-vs-Stage2
8.231600E-01
Normal-vs-Stage3
8.487700E-02
Normal-vs-Stage4
5.232000E-01
Stage1-vs-Stage2
7.314000E-01
Stage1-vs-Stage3
1.258780E-01
Stage1-vs-Stage4
5.122600E-01
Stage2-vs-Stage3
4.677600E-02
Stage2-vs-Stage4
6.345000E-01
Stage3-vs-Stage4
5.913800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.450800E-01
Normal-vs-AfricanAmerican
8.241000E-01
Normal-vs-Asian
3.404000E-01
Caucasian-vs-AfricanAmerican
9.761000E-01
Caucasian-vs-Asian
1.619230E-01
AfricanAmerican-vs-Asian
3.728600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.021800E-01
Normal-vs-Female
9.573600E-01
Male-vs-Female
1.678640E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.478160E-01
Normal-vs-Age(41-60Yrs)
5.088000E-01
Normal-vs-Age(61-80Yrs)
9.306200E-01
Normal-vs-Age(81-100Yrs)
8.320600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.5264999999971E-05
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.120500E-03
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.601900E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.474000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.953600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.716200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.398800E-01
Normal-vs-Daily Drinker
7.922200E-01
Normal-vs-Weekly Drinker
8.684000E-01
Normal-vs-Occasional Drinker
7.045000E-01
Normal-vs-Social Drinker
6.641000E-01
Non Drinker-vs-Daily Drinker
3.381600E-01
Non Drinker-vs-Weekly Drinker
8.717400E-01
Non Drinker-vs-Occasional Drinker
2.417000E-01
Non Drinker-vs-Social Drinker
2.682600E-01
Daily Drinker-vs-Weekly Drinker
4.580800E-01
Daily Drinker-vs-Occasional Drinker
7.409000E-01
Daily Drinker-vs-Social Drinker
8.024200E-01
Weekly Drinker-vs-Occasional Drinker
3.480400E-01
Weekly Drinker-vs-Social Drinker
3.204000E-01
Occasional Drinker-vs-Social Drinker
9.275400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.479000E-01
Normal-vs-Grade 2
5.930200E-01
Normal-vs-Grade 3
6.074800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.341800E-01
Grade 1-vs-Grade 3
8.997000E-01
Grade 1-vs-Grade 4
2.479000E-01
Grade 2-vs-Grade 3
7.383400E-01
Grade 2-vs-Grade 4
5.930200E-01
Grade 3-vs-Grade 4
6.074800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.836800E-01
Normal-vs-NonDiabetic
8.281600E-01
Diabetic-vs-NonDiabetic
5.277200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.689400E-01
Normal-vs-NoPancreatitis
7.988600E-01
Pancreatitis-vs-NoPancreatitis
5.792400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.457000E-01
Normal-vs-N1
8.205000E-01
N0-vs-N1
7.866200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.000400E-01
Normal-vs-TP53-NonMutant
8.876600E-01
TP53-Mutant-vs-TP53-NonMutant
3.130200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
